ArticleFrontiers in endocrinology2026
The gamma-glutamyltransferase-to-estimated glomerular filtration rate composite index is associated with arterial stiffness: a cross-sectional secondary analysis of a health check-up population.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elevated gamma-glutamyltransferase (GGT), a marker of oxidative stress and cardiometabolic burden, and reduced estimated glomerular filtration rate (eGFR) are each linked to arterial stiffness, but they are usually examined separately. This study evaluated whether a single index integrating both-the GGT-eGFR composite index-is associated with brachial-ankle pulse wave velocity (baPWV). Methods: This was a cross-sectional analysis of 893 adults from a Japanese health check-up program. The composite index was calculated as ln(GGT) × 100/eGFR. Its association with baPWV (continuous) and with elevated baPWV (≥1400 and ≥1600 cm/s) was assessed using multivariable linear and logistic regression, restricted cubic splines, joint GGT×eGFR stratification, subgroup analyses, and sensitivity analyses. Models containing the composite index were also compared with models containing ln(GGT), eGFR, or both components. Results: baPWV increased across index quartiles (1295 to 1531 cm/s). In the fully adjusted model, each 1-SD increment in the index was associated with a 20.46 cm/s higher baPWV (95% CI 5.64-35.28; P = 0.007); the highest versus lowest quartile difference was 74.77 cm/s (95% CI 33.96-115.57; P<0.001). The index was also associated with baPWV ≥1400 cm/s (OR 1.32, 95% CI 1.06-1.64) and ≥1600 cm/s (OR 1.36, 95% CI 1.04-1.79). Direct model comparisons showed a modest improvement in model fit for continuous baPWV after inclusion of the composite index, while categorical model performance was broadly comparable across models. Restricted cubic spline analysis showed an overall association with baPWV (P for overall = 0.011), with no statistically significant evidence of departure from linearity (P for non-linearity = 0.192). The association was consistent across sensitivity analyses. Conclusion: In this cross-sectional secondary analysis, a higher exploratory GGT-eGFR-derived index remained associated with higher baPWV after multivariable adjustment. Direct comparison with ln(GGT) and eGFR showed only modest differences in model fit, and prospective external validation is required before clinical application can be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.